Glycated Albumin Assay Market Share, Trend & Forecast 2034

Request Methodology

Glycated Albumin Assay Market Outlook from 2024 to 2034

The glycated albumin assay market is anticipated to reach US$ 223.9 million in 2024. The glycated albumin assay market is expected to expand at a CAGR of 8.4% from 2024 to 2034. The global glycated albumin assay market size is predicted to reach US$ 504 million by 2034.

Attributes	Key Insights
Estimated Market Size in 2024	US$ 223.9 million
Projected Market Value in 2034	US$ 504 million
Value-based CAGR from 2024 to 2034	8.4%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Market Trends and Highlights

New clinical applications for measuring glycated albumin might be discovered through ongoing research.
With the advancement of personalized medicine, glycemic control strategies can be tailored based on the characteristics of individual patients, including the amount of glycated albumin they produce.
Data analysis and integration using artificial intelligence will likely be more prevalent in the future, improving glucose control and providing greater insight into a patient's condition.
Virtual consultations are becoming more common among healthcare providers due to the adoption of telemedicine.
Access and convenience are expected to be improved through this trend.
Interoperability is being improved across health systems, enabling seamless exchange of patient information between them.

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

Glycated albumin assays are projected to increase at a CAGR of 10.6% from 2019 to 2023. The demand for eco-friendly products and services can increase as awareness of environmental issues and sustainability grows. Introducing new and improved products or services can drive market growth through innovation, research, and development investments.

Testing for various health parameters at the point of care is becoming increasingly popular. Increasing accessibility and speed of glycated albumin assays may facilitate quick monitoring of patients in various healthcare settings in the future.

Digital transformation is transforming industries and bringing new markets and business models. Digital technologies such as AI, data analytics, and IoT can help companies stay ahead of the competition. It is forecast that between 2024 and 2034, the market is expected to increase at a steady rate of 8.4%.

Historical CAGR from 2019 to 2023	10.6%
Forecast CAGR from 2024 to 2034	8.4%

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Glycated Albumin Assay Drivers

Rapid technological advancements often contribute to market growth. Innovative products and services can be developed using new technologies, as well as improved efficiency and possibilities for new businesses.
Consumer preferences and lifestyle changes can lead to a variety of new and different products and services being offered. Adapting to these changes can give companies an advantage over their competitors.
A change in regulations can have a significant impact on market dynamics. A regulatory shift, for instance, may provide entrepreneurs with the potential to take advantage of new consumer protection laws or provide a solution to emerging regulatory issues.
Increased globalization increases market share by reaching a broader customer base. As a result, competitive markets can also emerge, resulting in new markets. Changes in income levels, population growth, and population aging can also be significant factors.

Glycated Albumin Assay Challenges

A more common HbA1c assay uses albumin rather than hemoglobin due to its shorter half-life. As a result, GA can reflect recent changes in blood glucose levels since it represents a shorter period of glycemic control. The retrospective analysis is, however, limited by this comparison when compared with HbA1c.
The methods used to measure GA may vary in different laboratories, leading to variable results. The issue continues to be addressed through standardization and harmonization, but variations can still exist.
In addition to glycated albumin levels, total albumin levels can also be influenced by conditions such as liver and kidney disease. Interpretation of results is crucially dependent on taking these factors into account.
In comparison to tests like HbA1c, GA assays lack international standardization despite efforts to standardize them. As a result, results can be inconsistent and unreliable due to a lack of standardization.
The lack of GA assays and associated costs can be limited, particularly in resource-constrained environments. Compared to more established glycemic control markers, GA testing may be less widely adopted.

Comparative View of Adjacent Markets

Future Market Insights has compared three markets, namely the diabetes care devices and the blood glucose monitoring devices market below. The glycated albumin may someday replace HbA1c as an indicator of glycemic control.

This alternative is promising due to its ability to reflect changes in blood glucose levels on a short-term basis and its independence from hemoglobin. To make it widely available, more efforts must be made towards research and standardization.

Diabetes care devices facilitate monitoring and managing blood glucose levels in diabetics. Patients with diabetes seem to adhere more closely to their treatment plans and have better blood sugar control when using diabetes care devices. Using a device that fits a person's needs and lifestyle increases the likelihood of them adhering to its use, leading to improved health outcomes.

Individuals can quickly assess their blood glucose levels using blood glucose meters, which provide instant results. Diabetes management can be done more effectively with timely insulin dosage, dietary choices, and other decisions.

Data can be downloaded from many blood glucose monitors to computers and mobile devices. Sharing glucose results with healthcare professionals improves communication during medical visits and makes it easier for them to make informed decisions during medical visits.

Glycated Albumin Assay Market:

Attributes	Glycated Albumin Assay Market
CAGR from 2024 to 2034	8.4%
Key Trends	The digital health sector and telemedicine are key trends on the market in terms of medical care.
Growth Factor	With technological advances, glycated albumin measurements may become more precise and reliable, potentially leading to more sensitive and accurate tests.

Blood Glucose Monitoring Devices Market:

Attributes	Blood Glucose Monitoring Devices Market
CAGR from 2024 to 2034	4.9%
Key Trends	As diabetes and obesity rates rise, noninvasive and fast ways to monitor blood glucose levels are being developed.
Growth Factor	A significant increase in the number of diabetic cases and ongoing technological advances.

Diabetes Care Devices Market:

Attributes	Diabetes Care Devices Market
CAGR from 2022 to 2032	6.3%
Key Trends	Technological advancements and the diabetic population continue to lead to improvements in blood glucose monitoring devices.
Growth Factor	As healthy lifestyles and self-care become more prevalent, there is an increasing number of health-conscious individuals worldwide.

Country-wise Analysis

According to the table provided, South Korea is the largest revenue generator in the market. The global glycated albumin assay market is predicted to grow in response to a growing interest in medical technology and innovation.

A revolution in medical care could be brought about by advancements in mRNA-based therapies. As a result of these therapies, a wide range of diseases can be treated, including cancer and heart disease vaccines.

Countries	Forecast CAGRs from 2024 to 2034
The United States	8.7%
China	9%
Japan	6.8%
South Korea	9.8%
The United Kingdom	9.5%

Growing Need for Personalized Medicine is expected to Drive Demand in the United States

In the United States, glycated albumin assays are expected to be in high demand. The market is expected to expand at a CAGR of 8.7% during the forecast period.

The United States is seeing an increase in personalized medicine, emphasizing adapting therapies to particular patient needs. Diabetes care can be improved with more individualized treatment programs and improved management of glycated albumin levels based on glycated albumin assays.

Increasing Demand for Clinical Diagnostic Tests in China will Increase Glycated Albumin Assay Demand

Glycated albumin assay market growth is attributed to the growing prevalence of diabetes in China. A growth rate of 9% is anticipated between 2024 and 2034. The market is expected to reach US$ 78.5 million by 2034. As the number of diabetics continues to rise, there is an increasing need for clinical diagnostic tests that can provide accurate and reliable results to monitor glycemic control as it continues to rise.

Lifestyle changes, urbanization, and an aging population are contributing to an increase in diabetes prevalence in China. As diabetic populations grow, glycated albumin assays become increasingly important to monitor and manage their disease.

Rising Research and Development Activities to Drive the Market in Japan

With technological advances, Japan is expected to dominate the market. A 6.8% CAGR is forecast for the market during the forecast period. This market is expected to generate a total of US$ 41.9 million by 2034.

Healthcare and biotechnology research and development (R&D) have been strong areas of focus in Japan. Research and development investments in the diagnostic industry drive innovation, including in glycated albumin assays, which have become more accurate, efficient, and widely available in Japan.

Increasing Healthcare Spending in South Korea will Fuel Market Growth

Healthcare spending in South Korea has increased to improve quality and accessibility. With more people concentrating on preventing and managing chronic diseases, the demand for glycated albumin assays in South Korea is high. The market is anticipated to reach US$ 29.8 million by 2034. The market is expected to expand at a 9.8% CAGR during the forecast period.

Medical technology and innovation in South Korea have received much attention during the past few decades. Medical providers and patients in South Korea are increasingly adopting glycated albumin assays, which are becoming more accurate, reliable, and accessible due to technological advances.

Cost-Effective Treatment Options in the United Kingdom to Drive the Market

A CAGR of 9.5% is projected for the United Kingdom between 2024 and 2034. Healthcare in the United Kingdom is facing resource constraints and an increasing demand for services. Healthcare providers can optimize resources and improve patient outcomes by using glycated albumin assays for diabetic monitoring.

The United Kingdom has adopted national programs to improve diabetes care and prevent complications associated with the disease. Glycated albumin tests play an important part in these strategies because they provide healthcare practitioners with relevant data to improve diabetes management and lessen the burden on the healthcare system.

Category-wise Insights

This section illustrates the market's leading segment. Based on the application, the type 2 diabetes segment is expected to expand at a CAGR of 8.1% by 2034. Based on the end user, the hospitals & diabetic care center segment is expected to expand at a CAGR of 7.8% by 2034.

Category	CAGR from 2024 to 2034
Type 2 Diabetes	8.1%
Hospitals & Diabetic Care	7.8%

Technological Advances will improve the Diagnosis and Treatment of Type 2 Diabetes

By 2034, the type 2 diabetes sector is forecast to record a CAGR of 8.1%. A sedentary lifestyle, poor diet, and an aging population have all contributed to the increasing prevalence of type 2 diabetes worldwide. As the number of people with type 2 diabetes rises, there will be an increased demand for diagnostic instruments and monitoring approaches, such as glycated albumin assays.

Ongoing research and development in diagnostic technologies help improve tests, making them more accurate, sensitive, and user-pleasant. Technological developments may result in the development of point-of-care testing. Various methods for glycated albumin will make it more accessible to patients and healthcare practitioners.

Acute Patient Care is expected to dominate the Hospital and Diabetes Care Industries

The hospital & diabetic care segment is expected to expand at a CAGR of 7.8% until 2034. Glycated albumin assays are routinely used in hospitals and diabetic care centers to measure how effectively patients manage their blood glucose levels.

The ability to assess glycated albumin provides a more immediate snapshot of glycemic control than other markers, such as HbA1c, making it especially relevant in acute care settings.

Hospitals and diabetic care facilities can enhance their capabilities by developing point-of-care tests for glycated albumin. A clinical decision can be made immediately after the test due to the fast and on-site results.

Competitive Landscape

Competitive changes, like mergers and acquisitions, can change market dynamics. Business owners may face opportunities or challenges as a result of these changes.

Key Market Developments

Asahi Kasei Pharma Corporation- Asahi Kasei Pharma is a Japanese pharmaceutical firm that may research, develop, and manufacture various healthcare goods, including diagnostic tests. They may be engaged in developing assays for glycated albumin, a biomarker linked to diabetes.
EKF Diagnostics Holdings plc- EKF Diagnostics is a multinational medical diagnostics firm that creates and produces diagnostic tools and equipment. They may have a variety of diabetes management assays, including ones that measure glycated albumin levels.
Weldon Biotech India Private Limited- Weldon Biotech, established in India, is likely involved in the biotechnology industry. They may concentrate on researching and producing biotechnological goods, such as assays for various uses, including glycated albumin assays.

Key Coverage of Glycated Albumin Assay Report

Study on glycated albumin assays, Performance Evaluation of Glycated Albumin Assays
Opportunity Analysis of the Glycated Albumin Assay
Glycated Albumin Assay Market Scenario
South Korea Glycated Albumin Assay in the Market
Competitive Analysis of Top Glycated Albumin Assay and Support Companies

Report Scope

Attributes	Details
Estimated Market Size in 2024	US$ 223.9 million
Projected Market Valuation in 2034	US$ 504 million
Value-based CAGR 2024 to 2034	8.4%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ million
Key Regions Covered	North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East and Africa
Key Market Segments Covered	Application End User Region
Key Countries Profiled	The United States Canada Brazil Mexico Germany United Kingdom France Spain Italy Poland Russia Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel
Key Companies Profiled	Asahi Kasei Pharma Corporation EKF Diagnostics Holdings plc Weldon Biotech India Private Limited Hzymes Biotechnology Co. Ltd. Beijing Strong Biotechnologies Inc. Diazyme Laboratories Inc. (General Atomics) Abbexa Limited Biomatik Corporation Abnova Corporation Geno Technology Inc.

Glycated Albumin Assay - Key Segments

By Application:

Type 2 Diabetes
Type 1 Diabetes
Prediabetes

By End User:

Hospitals & Diabetic Care Centers
Diagnostic Laboratories
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

Frequently Asked Questions

What is the estimated value of the glycated albumin assay in 2024?

As of 2024, the glycated albumin assay market is expected to be valued at US$ 223.9 million.

What is the anticipated market value for the glycated albumin assay in 2034?

By 2034, the market value of the glycated albumin assay is expected to reach US$ 504 million.

What is the projected forecast CAGR for the glycated albumin assay from 2024 to 2034?

From 2024 to 2034, the glycated albumin assay is expected to flourish at a CAGR of 8.4%

Based on application, which segment dominates the glycated albumin assay?

The type 2 diabetes segment is expected to register at 8.1% CAGR by 2034.

Which country is likely to dominate the glycated albumin assay?

South Korea is expected to hold the largest market, with a CAGR of 9.8%.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034

5.3.1. Type 2 Diabetes

5.3.2. Type 1 Diabetes

5.3.3. Prediabetes

5.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034

6.3.1. Hospitals & Diabetic Care Center

6.3.2. Diagnostic Laboratory

6.3.3. Others

6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

7.3.1. North America

7.3.2. Latin America

7.3.3. Western Europe

7.3.4. Eastern Europe

7.3.5. South Asia and Pacific

7.3.6. East Asia

7.3.7. Middle East and Africa

7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

8.2.1. By Country

8.2.1.1. UNITED STATES

8.2.1.2. Canada

8.2.2. By Application

8.2.3. By End User

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Application

8.3.3. By End User

8.4. Key Takeaways

9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Application

9.2.3. By End User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Application

9.3.3. By End User

9.4. Key Takeaways

10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. UNITED KINGDOM

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Western Europe

10.2.2. By Application

10.2.3. By End User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Application

10.3.3. By End User

10.4. Key Takeaways

11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Poland

11.2.1.2. Russia

11.2.1.3. Czech Republic

11.2.1.4. Romania

11.2.1.5. Rest of Eastern Europe

11.2.2. By Application

11.2.3. By End User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Application

11.3.3. By End User

11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. India

12.2.1.2. Bangladesh

12.2.1.3. Australia

12.2.1.4. New Zealand

12.2.1.5. Rest of South Asia and Pacific

12.2.2. By Application

12.2.3. By End User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Application

12.3.3. By End User

12.4. Key Takeaways

13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. China

13.2.1.2. Japan

13.2.1.3. South Korea

13.2.2. By Application

13.2.3. By End User

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Application

13.3.3. By End User

13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. GCC Countries

14.2.1.2. South Africa

14.2.1.3. Israel

14.2.1.4. Rest of MEA

14.2.2. By Application

14.2.3. By End User

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Application

14.3.3. By End User

14.4. Key Takeaways

15. Key Countries Market Analysis

15.1. UNITED STATES

15.1.1. Pricing Analysis

15.1.2. Market Share Analysis, 2023

15.1.2.1. By Application

15.1.2.2. By End User

15.2. Canada

15.2.1. Pricing Analysis

15.2.2. Market Share Analysis, 2023

15.2.2.1. By Application

15.2.2.2. By End User

15.3. Brazil

15.3.1. Pricing Analysis

15.3.2. Market Share Analysis, 2023

15.3.2.1. By Application

15.3.2.2. By End User

15.4. Mexico

15.4.1. Pricing Analysis

15.4.2. Market Share Analysis, 2023

15.4.2.1. By Application

15.4.2.2. By End User

15.5. Germany

15.5.1. Pricing Analysis

15.5.2. Market Share Analysis, 2023

15.5.2.1. By Application

15.5.2.2. By End User

15.6. UNITED KINGDOM

15.6.1. Pricing Analysis

15.6.2. Market Share Analysis, 2023

15.6.2.1. By Application

15.6.2.2. By End User

15.7. France

15.7.1. Pricing Analysis

15.7.2. Market Share Analysis, 2023

15.7.2.1. By Application

15.7.2.2. By End User

15.8. Spain

15.8.1. Pricing Analysis

15.8.2. Market Share Analysis, 2023

15.8.2.1. By Application

15.8.2.2. By End User

15.9. Italy

15.9.1. Pricing Analysis

15.9.2. Market Share Analysis, 2023

15.9.2.1. By Application

15.9.2.2. By End User

15.10. Poland

15.10.1. Pricing Analysis

15.10.2. Market Share Analysis, 2023

15.10.2.1. By Application

15.10.2.2. By End User

15.11. Russia

15.11.1. Pricing Analysis

15.11.2. Market Share Analysis, 2023

15.11.2.1. By Application

15.11.2.2. By End User

15.12. Czech Republic

15.12.1. Pricing Analysis

15.12.2. Market Share Analysis, 2023

15.12.2.1. By Application

15.12.2.2. By End User

15.13. Romania

15.13.1. Pricing Analysis

15.13.2. Market Share Analysis, 2023

15.13.2.1. By Application

15.13.2.2. By End User

15.14. India

15.14.1. Pricing Analysis

15.14.2. Market Share Analysis, 2023

15.14.2.1. By Application

15.14.2.2. By End User

15.15. Bangladesh

15.15.1. Pricing Analysis

15.15.2. Market Share Analysis, 2023

15.15.2.1. By Application

15.15.2.2. By End User

15.16. Australia

15.16.1. Pricing Analysis

15.16.2. Market Share Analysis, 2023

15.16.2.1. By Application

15.16.2.2. By End User

15.17. New Zealand

15.17.1. Pricing Analysis

15.17.2. Market Share Analysis, 2023

15.17.2.1. By Application

15.17.2.2. By End User

15.18. China

15.18.1. Pricing Analysis

15.18.2. Market Share Analysis, 2023

15.18.2.1. By Application

15.18.2.2. By End User

15.19. Japan

15.19.1. Pricing Analysis

15.19.2. Market Share Analysis, 2023

15.19.2.1. By Application

15.19.2.2. By End User

15.20. South Korea

15.20.1. Pricing Analysis

15.20.2. Market Share Analysis, 2023

15.20.2.1. By Application

15.20.2.2. By End User

15.21. GCC Countries

15.21.1. Pricing Analysis

15.21.2. Market Share Analysis, 2023

15.21.2.1. By Application

15.21.2.2. By End User

15.22. South Africa

15.22.1. Pricing Analysis

15.22.2. Market Share Analysis, 2023

15.22.2.1. By Application

15.22.2.2. By End User

15.23. Israel

15.23.1. Pricing Analysis

15.23.2. Market Share Analysis, 2023

15.23.2.1. By Application

15.23.2.2. By End User

16. Market Structure Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Market Share Analysis of Top Players

16.3.1. By Regional

16.3.2. By Application

16.3.3. By End User

17. Competition Analysis

17.1. Competition Deep Dive

17.1.1. Asahi Kasei Pharma Corporation

17.1.1.1. Overview

17.1.1.2. Product Portfolio

17.1.1.3. Profitability by Market Segments

17.1.1.4. Sales Footprint

17.1.1.5. Strategy Overview

17.1.1.5.1. Marketing Strategy

17.1.2. EKF Diagnostics Holdings plc

17.1.2.1. Overview

17.1.2.2. Product Portfolio

17.1.2.3. Profitability by Market Segments

17.1.2.4. Sales Footprint

17.1.2.5. Strategy Overview

17.1.2.5.1. Marketing Strategy

17.1.3. Weldon Biotech India Private Limited

17.1.3.1. Overview

17.1.3.2. Product Portfolio

17.1.3.3. Profitability by Market Segments

17.1.3.4. Sales Footprint

17.1.3.5. Strategy Overview

17.1.3.5.1. Marketing Strategy

17.1.4. Hzymes Biotechnology Co., Ltd.

17.1.4.1. Overview

17.1.4.2. Product Portfolio

17.1.4.3. Profitability by Market Segments

17.1.4.4. Sales Footprint

17.1.4.5. Strategy Overview

17.1.4.5.1. Marketing Strategy

17.1.5. Beijing Strong Biotechnologies, Inc.

17.1.5.1. Overview

17.1.5.2. Product Portfolio

17.1.5.3. Profitability by Market Segments

17.1.5.4. Sales Footprint

17.1.5.5. Strategy Overview

17.1.5.5.1. Marketing Strategy

17.1.6. Diazyme Laboratories, Inc. (General Atomics)

17.1.6.1. Overview

17.1.6.2. Product Portfolio

17.1.6.3. Profitability by Market Segments

17.1.6.4. Sales Footprint

17.1.6.5. Strategy Overview

17.1.6.5.1. Marketing Strategy

17.1.7. Abbexa Limited

17.1.7.1. Overview

17.1.7.2. Product Portfolio

17.1.7.3. Profitability by Market Segments

17.1.7.4. Sales Footprint

17.1.7.5. Strategy Overview

17.1.7.5.1. Marketing Strategy

17.1.8. Biomatik Corporation

17.1.8.1. Overview

17.1.8.2. Product Portfolio

17.1.8.3. Profitability by Market Segments

17.1.8.4. Sales Footprint

17.1.8.5. Strategy Overview

17.1.8.5.1. Marketing Strategy

17.1.9. Abnova Corporation

17.1.9.1. Overview

17.1.9.2. Product Portfolio

17.1.9.3. Profitability by Market Segments

17.1.9.4. Sales Footprint

17.1.9.5. Strategy Overview

17.1.9.5.1. Marketing Strategy

17.1.10. Geno Technology, Inc.

17.1.10.1. Overview

17.1.10.2. Product Portfolio

17.1.10.3. Profitability by Market Segments

17.1.10.4. Sales Footprint

17.1.10.5. Strategy Overview

17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 4: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 5: North America Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 6: North America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 8: Latin America Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 11: Western Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 12: Western Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Eastern Europe Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 15: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 20: East Asia Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 21: East Asia Market Value (US$ Million) Forecast by End User, 2019 to 2034

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2019 to 2034

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019 to 2034

List of Charts

Figure 1: Global Market Value (US$ Million) by Application, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by End User, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 7: Global Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 8: Global Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 9: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 10: Global Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 13: Global Market Attractiveness by Application, 2024 to 2034

Figure 14: Global Market Attractiveness by End User, 2024 to 2034

Figure 15: Global Market Attractiveness by Region, 2024 to 2034

Figure 16: North America Market Value (US$ Million) by Application, 2024 to 2034

Figure 17: North America Market Value (US$ Million) by End User, 2024 to 2034

Figure 18: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 19: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 22: North America Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 23: North America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 24: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 25: North America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 28: North America Market Attractiveness by Application, 2024 to 2034

Figure 29: North America Market Attractiveness by End User, 2024 to 2034

Figure 30: North America Market Attractiveness by Country, 2024 to 2034

Figure 31: Latin America Market Value (US$ Million) by Application, 2024 to 2034

Figure 32: Latin America Market Value (US$ Million) by End User, 2024 to 2034

Figure 33: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 37: Latin America Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 43: Latin America Market Attractiveness by Application, 2024 to 2034

Figure 44: Latin America Market Attractiveness by End User, 2024 to 2034

Figure 45: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 46: Western Europe Market Value (US$ Million) by Application, 2024 to 2034

Figure 47: Western Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 48: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 52: Western Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 55: Western Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 58: Western Europe Market Attractiveness by Application, 2024 to 2034

Figure 59: Western Europe Market Attractiveness by End User, 2024 to 2034

Figure 60: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 61: Eastern Europe Market Value (US$ Million) by Application, 2024 to 2034

Figure 62: Eastern Europe Market Value (US$ Million) by End User, 2024 to 2034

Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 70: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 73: Eastern Europe Market Attractiveness by Application, 2024 to 2034

Figure 74: Eastern Europe Market Attractiveness by End User, 2024 to 2034

Figure 75: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 76: South Asia and Pacific Market Value (US$ Million) by Application, 2024 to 2034

Figure 77: South Asia and Pacific Market Value (US$ Million) by End User, 2024 to 2034

Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 88: South Asia and Pacific Market Attractiveness by Application, 2024 to 2034

Figure 89: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034

Figure 90: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 91: East Asia Market Value (US$ Million) by Application, 2024 to 2034

Figure 92: East Asia Market Value (US$ Million) by End User, 2024 to 2034

Figure 93: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 97: East Asia Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 98: East Asia Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 100: East Asia Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 101: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 102: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 103: East Asia Market Attractiveness by Application, 2024 to 2034

Figure 104: East Asia Market Attractiveness by End User, 2024 to 2034

Figure 105: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 106: Middle East and Africa Market Value (US$ Million) by Application, 2024 to 2034

Figure 107: Middle East and Africa Market Value (US$ Million) by End User, 2024 to 2034

Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2019 to 2034

Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024 to 2034

Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034

Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019 to 2034

Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034

Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034

Figure 118: Middle East and Africa Market Attractiveness by Application, 2024 to 2034

Figure 119: Middle East and Africa Market Attractiveness by End User, 2024 to 2034

Figure 120: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

February 2024

REP-GB-19147

281 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 3287 4268 + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

Glycated Albumin Assay Market

Glycated Albumin Assay Market Analysis by End Users including Hospitals and Diabetic Care Centers, Diagnostic Laboratories and Others from 2024 to 2034